Category Archives: Genetic Engineering

GENETIC ENGINEERING: Cow/Pig CREATURE will be on your DINNER PLATE
Hybrid cow/pig meat is threatening cities on a global level. Please watch, share, and write your congress persons. If this scientific experimentation on FOOD continues, mass deaths will occur.

By: Total Vids Lists

Link:
GENETIC ENGINEERING: Cow/Pig CREATURE will be on your DINNER PLATE - Video

November 29, 2014

"Spider silk' is stronger than conventional silk and could be used for textiles

TOKYO: Japanese scientists have developed through genetic engineering using genes from spiders and silkworms a super resistant silk which could be used for textiles as well as in the surgical field, media reported on Friday.

Known as Spider Silk, which is stronger and smoother than conventional silk, it has been developed by researchers at Shinshu University, the Asahi daily newspaper reported.

Masao Nakagaki from the Faculty of Textile Science and Technology was the first person, in 2007, to implant spider genes in silkworms, resulting in the production of silk which had some components of spider webs.

Several years of research has now led to the development of spider silk which has less than 20 per cent of the components of spider webs.

Several prototypes of socks have also been manufactured using this new material.

It is expected that the hybrid silk would be used in the textile industry, and for manufacturing surgical threads and artificial blood vessels.

The university reached an agreement with the local government to commercially produced the hybrid silk.

Both institutions have decided to collaborate in areas of industrial development, training of personnel, academic research and use of facilities for commercial production of the silk, according to Asahi.

See the original post:
Scientists develop hybrid silk using spider genes

Islam, Genetic Engineering and Bioethics /
Interview with Dr. Rana Dajani.

By: TVIslamScience

Original post:
Islam, Genetic Engineering and Bioethics / - Video

Topic: It has criticised genetic engineering. insurance (voice)
Listen today about new interesting topic - It has criticised genetic engineering. insurance. *---*---*---*---*---*---*---*---*---*--*---*---*---* Check out ...

By: Richness Pedia

See original here:
Topic: It has criticised genetic engineering. insurance (voice) - Video

Advanced CRISPR Cas9 Genetic Engineering
The CRISPR Cas9 system has been harnessed to create a simple, RNA programmable method to mediate genome editing in mammalian cells, and can be used to generate gene knockouts (via ...

By: William Orfanos

Visit link:
Advanced CRISPR Cas9 Genetic Engineering - Video

Genetic Engineering: The Super Banana
Project for APES. By Sydney Hsueh and Jenny Lee.

By: Sydney Hsueh

Read more:
Genetic Engineering: The Super Banana - Video

With an MBA from the University of Chicago (2006) and an MSc from the Compigne University of Technology (1997), David Del Bourgo has combined education in management and biomedical engineering. He has acquired 17 years of experience in marketing and sales development within the healthcare industry.

Before joining Genomic Vision, David Del Bourgo was VP Sales and Marketing at Theraclion, which specializes in therapeutic ultrasound equipment. After joining the company in 2009, he instigated Theraclions marketing strategy, developed the network of key opinion leaders and deployed the direct and indirect sales of an innovative echotherapy solution, which established the company as a major player in the treatment of tumors by ultrasound.

From 2006 to 2009, David was Director of Corporate Development and Marketing at Orbotech, a NASDAQ-listed Israeli electronics company, where he notably contributed to the growth of their medical division and led the acquisition of a Danish company specializing in nuclear cardiology (turnover of $30 million). His other positions have included Manager in Strategic Consulting at Advention Business Partners (2005-2006) and various positions at General Electric Healthcare, where he was initially a researcher (1997) before being appointed International Product Marketing Manager (2001-2003).

At Genomic Vision, Davids mission has begun with the setting up of a Sales and Marketing team, which is already operational, consisting of product specialists and a field team whose aim will be to promote the Companys innovative genetic tests among the main European diagnostic centers.

Aaron Bensimon, Genomic Visions co-founder and Chairman, says: We are very pleased to be able to count on a manager with such experience at Genomic Vision. David and his team are highly driven by their objective of deploying our international marketing strategy. His expertise and knowledge of the sector represent real assets in identifying sales opportunities for the genetic tests we are developing, and notably those targeting breast and colon cancer, which are scheduled to be launched in 2015.

Next financial press release

ABOUT GENOMIC VISION A spinoffof the Institut Pasteur, Genomic Vision is a molecular diagnostics company specialized in developing diagnostic tests for genetic diseases and cancers. Using molecular combing, an innovative technology that allows the direct visualization of individual DNA molecules, Genomic Vision detects quantitative and qualitative variations in the genome that are at the origin of numerous serious pathologies. Having benefited from the financial support of the Institut Pasteur, SGAM AI, Vesalius Biocapital and Quest Diagnostics, the Company is developing a solid portfolio of tests that notably target breast cancer and cancer of the colon. Since 2013, the Company has marketed the CombHeliX FSHD test for identifying a myopathy that is difficult to detect, Facio-scapulo-humeral dystrophy (FSHD), in the United States thanks to a strategic alliance with Quest Diagnostics, the American leader in diagnostic laboratory tests, and in France.

ABOUT MOLECULAR COMBING DNA molecular combing technology considerably improves the structural and functional analysis of DNA molecules. DNA fibers are stretched out on glass slides, as if combed, and uniformly aligned over the whole surface. It is then possible to identify genetic anomalies by locating genes or specific sequences in a patients genome using genetic markers, an approach developed by Genomic Vision and patented under the name Genomic Morse Code. This exploration of the entire genome at high resolution via a simple analysis enables the direct visualization of genetic anomalies that are undetectable by other technologies.

For further information, please go to http://www.genomicvision.com

Continue reading here:
Genomic Vision Appoints David Del Bourgo as Head of Sales and Marketing

PUBLIC RELEASE DATE:

24-Nov-2014

Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline

New Rochelle, NY, November 24, 2014--Genetically engineered pigs, minipigs, and microminipigs are valuable tools for biomedical research, as their lifespan, anatomy, physiology, genetic make-up, and disease mechanisms are more similar to humans than the rodent models typically used in drug discovery research. A Comprehensive Review article entitled "Current Progress of Genetically Engineered Pig Models for Biomedical Research," describing advances in techniques to create and use pig models and their impact on the development of novel drugs and cell and gene therapies, is published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the BioResearch Open Access website at http://online.liebertpub.com/doi/full/10.1089/biores.2014.0039.

Gkhan Gn and Wilfried Kues, Friedrich-Loeffler-Institute (Neustadt, Germany), Istanbul Technical University, and Istanbul University Faculty of Veterinary Medicine (Turkey), discuss the technologies that have made it possible to develop transgenic pig models of human diseases, such as targeted gene transfer and genome sequencing. The authors review current progress in creating transgenic pig models for cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, ophthalmology, and xenotransplantation. These models will enable researchers to study disease processes, identify new drug targets, test novel cell therapies to restore diseased tissues and organs, and assess methods to correct or replace mutated genes.

"This review provides an excellent update of recent progress in the field of pig transgenics for biomedical research," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland.

###

About the Journal

BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal provides a new rapid-publication forum for a broad range of scientific topics including molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and are fully open access and posted on PubMed Central. All journal content is available on the BioResearch Open Access website at http://www.liebertpub.com/biores.

About the Publisher

View post:
New treatments for cancer, diabetes, and heart disease -- you may have a pig to thank

Catholic Edge Genetic Engineering HD
Video By: Austin Riordan.

By: Anna Landis

Read more from the original source:
Catholic Edge Genetic Engineering HD - Video

Might a GMO potato really be a better potato than can win over opponents of genetic engineering and feed the French fry minions? Image: J.R. Simply.

J.R. Simplot won federal approval for a genetically modified potato on Nov. 7, and although it is a major supplier of french fries to McDonald's , don't worry about some GMO spud showing up in your Happy Meal. The fast-food chain says it has no plans on adopting it anytime soon.

But that might not be the case for long.

Simplot says that because its new potato is made from genes derived from potatoes themselves and not bacteria or genes from other species, thus creating some sort of Frankenfood, it doesn't rise to the same level of concern activists would have over some crops, or when they thwarted Monsanto's effort to propagate a GMO potato in the 1990's.

Back then, Monsanto got the FDA to approve its New Leaf potatoes that were resistant to disease and insects through the development of a synthetic version of the bacillus thuringiensis bacterium, or Bt.

After initial acclaim, the biotech charged high premiums for its seed, which limited adoption, and then ultimately went nowhere when McDonald's and the Frito-Lay division of PepsiCo were cowed by anti-GMO activists into rejecting them. J.R. Simplot, an early adopter of the GMO potato, instructed its farmers not to plant them. Monsanto eventually stopped developing the potato in 2001.

Simplot's new Innate potatoes was developed to be especially beneficial to fast-food restaurants that sell lots of french fries. It's a little science-y, but it's important to understanding what Simplot is doing.

When potatoes and other starchy foods like bread (and even coffee!) are processed at high temperatures, such as when they're deep-fried, a carcinogenic chemical compound called acrylamide if formed.

More:
A GMO Potato Is Approved, But Will Anyone Buy It?